Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study

BackgroundVenous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a major cause of morbidity and mortality in patients with obesity. Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been associated with weight loss and potential r...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, Hsuan-Yuan Chang, Yu-Min Lin
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-05-01
Col·lecció:	Frontiers in Medicine
Matèries:	deep vein thrombosis glucagon-like peptide-1 receptor agonists obesity pulmonary embolism tirzepatide venous thromboembolism
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1820366/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!